Gastroesophageal reflux Trials in Miami, United States
Conditions / Gastroesophageal reflux / Miami, United States
Research into Gastroesophageal reflux spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00246909 | Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340) | COMPLETED | PHASE4 |
| NCT00362609 | Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERD | COMPLETED | PHASE3 |
| NCT00259012 | Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD | COMPLETED | PHASE3 |
| NCT00627016 | A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn | COMPLETED | PHASE3 |
| NCT00300755 | Study Evaluating Pantoprazole in Children With Gastroesophageal Reflux Disease (GERD) | COMPLETED | PHASE3 |
| NCT00141817 | Study Evaluating Pantoprazole in Children With GERD | COMPLETED | PHASE3 |
| NCT00365300 | Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) | COMPLETED | PHASE3 |
| NCT05556824 | Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD | RECRUITING | PHASE2 |
| NCT00992589 | Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Erosive Reflux Disease (GERD) | COMPLETED | PHASE3 |
| NCT00868296 | Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) | COMPLETED | PHASE3 |